ADAMIS PHARMACEUTICALS CORP's ticker is and the CUSIP is 00547W958. A total of 2 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | – | 2,700 | +22.7% | 0.00% | – |
| Q4 2022 | $0 | – | 2,200 | +29.4% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 1,700 | -55.3% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 3,800 | -13.6% | 0.00% | – |
| Q1 2022 | $2,000 | – | 4,400 | +214.3% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 1,400 | -92.0% | 0.00% | – |
| Q3 2021 | $19,000 | 0.0% | 17,400 | 0.0% | 0.00% | – |
| Q2 2021 | $19,000 | -80.4% | 17,400 | +1569.9% | 0.00% | – |
| Q1 2021 | $97,000 | – | 1,042 | +25950.0% | 0.00% | – |
| Q4 2020 | $0 | – | 4 | -33.3% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 6 | -90.8% | 0.00% | – |
| Q2 2019 | $8,000 | -38.5% | 65 | -1.5% | 0.00% | – |
| Q1 2019 | $13,000 | -53.6% | 66 | -48.0% | 0.00% | – |
| Q4 2018 | $28,000 | -83.1% | 127 | -73.3% | 0.00% | -100.0% |
| Q3 2018 | $166,000 | +3220.0% | 476 | +2544.4% | 0.00% | – |
| Q2 2018 | $5,000 | +400.0% | 18 | -60.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 45 | +275.0% | 0.00% | – |
| Q4 2017 | $1,000 | – | 12 | +140.0% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 5 | -96.4% | 0.00% | – |
| Q2 2017 | $4,000 | – | 140 | +4566.7% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 3 | -85.0% | 0.00% | – |
| Q3 2016 | $4,000 | -73.3% | 20 | -50.0% | 0.00% | -100.0% |
| Q2 2016 | $15,000 | – | 40 | +700.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 5 | -76.2% | 0.00% | – |
| Q1 2015 | $2,000 | – | 21 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 2,700 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |